Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies

OBJECTIVE: To examine the likelihood of response with continued galcanezumab treatment in patients with episodic or chronic migraine without initial clinical improvement. BACKGROUND: A percentage of patients with migraine may require additional time on pharmacotherapy but discontinue treatment prema...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Headache
Egile Nagusiak: Nichols, Russell, Doty, Erin, Sacco, Sara, Ruff, Dustin, Pearlman, Eric, Aurora, Sheena K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Research Submissions
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587751/
https://ncbi.nlm.nih.gov/pubmed/30462830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13443
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak